Gut Dysbiosis during Influenza Contributes to Pulmonary Pneumococcal Superinfection through Altered Short-Chain Fatty Acid Production

Valentin Sencio(Centre National de la Recherche Scientifique), Adeline Barthélémy(Centre National de la Recherche Scientifique), Luciana P. Tavares(Universidade Federal de Minas Gerais), Marina Machado(Universidade Federal de Minas Gerais), Daphnée Soulard(Centre National de la Recherche Scientifique), Céline Cuinat(AgroParisTech), Celso Martins Queiroz‐Junior(Universidade Federal de Minas Gerais), Marie-Louise Noordine(AgroParisTech), Sophie Salomé‐Desnoulez(Centre National de la Recherche Scientifique), Lucie Deryuter(Centre National de la Recherche Scientifique), Benoît Foligné(Inserm), Céline Wahl, Benoı̂t Frisch(Centre National de la Recherche Scientifique), Angélica T. Vieira(Universidade Federal de Minas Gerais), Christophe Paget(Centre National de la Recherche Scientifique), Graeme Milligan(University of Glasgow), Trond Ulven(University of Copenhagen), Isabelle Wolowczuk(Centre National de la Recherche Scientifique), Christelle Faveeuw(Centre National de la Recherche Scientifique), Ronan Le Goffic(Université Paris-Saclay), Muriel Thomas(AgroParisTech), Stéphanie Ferreira, Mauro Martins Teixeira(Universidade Federal de Minas Gerais), François Trottein(Centre National de la Recherche Scientifique)
Cell Reports
March 1, 2020
Cited by 348Open Access
Full Text

Abstract

Secondary bacterial infections often complicate viral respiratory infections. We hypothesize that perturbation of the gut microbiota during influenza A virus (IAV) infection might favor respiratory bacterial superinfection. Sublethal infection with influenza transiently alters the composition and fermentative activity of the gut microbiota in mice. These changes are attributed in part to reduced food consumption. Fecal transfer experiments demonstrate that the IAV-conditioned microbiota compromises lung defenses against pneumococcal infection. In mechanistic terms, reduced production of the predominant short-chain fatty acid (SCFA) acetate affects the bactericidal activity of alveolar macrophages. Following treatment with acetate, mice colonized with the IAV-conditioned microbiota display reduced bacterial loads. In the context of influenza infection, acetate supplementation reduces, in a free fatty acid receptor 2 (FFAR2)-dependent manner, local and systemic bacterial loads. This translates into reduced lung pathology and improved survival rates of double-infected mice. Lastly, pharmacological activation of the SCFA receptor FFAR2 during influenza reduces bacterial superinfection.


Related Papers

No related papers found

Powered by citation graph analysis